Abstract:Accurately predicting drug sensitivity and understanding what is driving it are major challenges in drug discovery. Graphs are a natural framework for capturing diverse pharmacological data for efficacy predictions, thanks to their ability to integrate multimodal data and represent relationships such as gene-gene or drug-target interactions as edges. They have also had proven success across a range of other drug discovery tasks including repositioning and target identification. In this study, we sought to address the explainability challenges of drug response predictions. Recent developments in the field of Graph AI have led to improvements in interpretability mechanisms that highlight parts of a graph which are driving predictions. We have conducted a comprehensive review of multiple major approaches for tackling drug efficacy prediction using graph methods, benchmarking the performance and interpretability of these algorithms across indications. Methods: We assembled a combined dataset of GDSC1 and GDSC2 drug response data in cell lines, with multiomic cell line data and drug target and chemical structure data. We then applied graph-based approaches for the prediction of binarized IC50 on an indication-by-indication basis. Approach 1 involved the creation of a 'GDSC knowledge graph', where drug response and cell line 'omic information is represented in an unweighted knowledge graph: cell lines are connected to genes expressed in them, drugs are connected to genes they target, and so on. We then used state-of-the-art graph embedding techniques to predict IC50 using paired drug and cell line embeddings. In Approach 2 we used a weighted knowledge graph instead, and generated embeddings using heterogeneous graph neural networks (HGNNs). In Approach 3, we modelled response prediction as a graph classification task, where one single graph captures one drug-cell line interaction. The graph classifier and HGNN models both have in-built interpretability mechanisms, including graph attention, that can signify the genes in the cell line which were most important for the eventual prediction. We can also integrate biomedical prior knowledge with all these models by capturing gene-pathway and gene-gene data in the graphs. Results: Our models outperformed benchmark models including DNNs and GBMs, and identified both established and novel response biomarkers in NSCLC cell lines (AUC = 0.94, Accuracy = 89%). We have also applied our models to Breast Cancer, Pancreatic Cancer, Colorectal Cancer and Haematological malignancies with similar predictive performance and explainability. Conclusions:Our graph analytical framework for response predictions showed better performance than benchmarking models and provided insights from explainability. This framework is easily extendable to response and 'omic data from any disease model and patient studies. Citation Format: Jake Cohen-Setton, Krishna Bulusu, Jonathan Dry, Ben Sidders. Explainable AI: Graph machine learning for response prediction and biomarker discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 902.

drGAT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network

TGSA: protein-protein association-based twin graph neural networks for drug response prediction with similarity augmentation

DGDRP: drug-specific gene selection for drug response prediction via re-ranking through propagating and learning biological network

GPDRP: a multimodal framework for drug response prediction with graph transformer

GATher: Graph Attention Based Predictions of Gene-Disease Links

DRPreter: Interpretable Anticancer Drug Response Prediction Using Knowledge-Guided Graph Neural Networks and Transformer

GADRP: graph convolutional networks and autoencoders for cancer drug response prediction

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention network

MDMNI-DGD: A novel graph neural network approach for druggable gene discovery based on the integration of multi-omics data and the multi-view network

Prediction of drug-likeness using graph convolutional attention network

Abstract 902: Explainable AI: Graph machine learning for response prediction and biomarker discovery

SGCLDGA: Unveiling Drug-Gene Associations Through Simple Graph Contrastive Learning

A Novel Approach For Drug Response Prediction In Cancer Cell Lines Via Network Representation Learning

Transfer learning of condition-specific perturbation in gene interactions improves drug response prediction

Dual-Layer Strengthened Collaborative Topic Regression Modeling for Predicting Drug Sensitivity

SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures

HMM-GDAN: Hybrid Multi-View and Multi-Scale Graph Duplex-Attention Networks for Drug Response Prediction in Cancer.

DRN-CDR: A cancer drug response prediction model using multi-omics and drug features

A novel heterogeneous network-based method for drug response prediction in cancer cell lines

Interpretable Dynamic Directed Graph Convolutional Network for Multi-Relational Prediction of Missense Mutation and Drug Response